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ABSTRACT
Autism is a pervasive, neurodevelopmental disorder characterized by stereotyped movements and impairment in social skills 
and communication patterns. Prevalence patterns show an increasing burden of about 1 in 150 children affected by the disor-
der. Most affected individuals have symptoms that interfere greatly with quality of life. Although a burgeoning concern, research 
on the prevalence, etiological factors and presentation patterns is limited in LAMI countries, leading to a minimal understanding 
of the disorder at individual, professional and societal level. There is an urgent need to enhance awareness and education to 
decrease stigma that maybe associated with autism. Partnering with entities like Autism Speaks is a potential step forward as 
they partner with local stakeholders to develop a culturally appropriate campaign focusing on the need for early diagnosis and 
intervention. For a country with very limited local resources, a collaborative approach with international partners is imperative 
to develop research, training and services for developmental disorders within our current and existing health systems.Autism is 
a pervasive, neurodevelopmental, clinically complex disorder that interferes with a person’s ability to communicate and relate 
to others. It require multiple and timely interventions to alleviate common clinical targets, such as impaired social skills and 
communication, executive functioning, empathy and perspective taking, sensory perception, and motor skills, along with 
restricted and circumscribed interests and often co-occurring psychiatric disorders (1). While some individuals are able to lead 
independent lives, most of those affected by the disorder have symptoms that interfere greatly with quality of life.  Although new 
research is working on developing screening and diagnostic measures for children as young as 12-18 months, ASDs can be 
reliably diagnosed behaviorally by age 2. ASD screening is recommended for all children at age 18 and 24 months. Early 
intervention in an educational/therapeutic setting is shown to bring about considerable improvement in areas of language, 
social skills as well as cognitive ability. While there is no known cure for ASDs, research has shown that improvement in 
language is directly associated with better prognosis.Prevalence Since the earliest epidemiological surveys in the 1960s, a 
wealth of data has become available, indicating a much higher prevalence of the condition than previously thought [2,3,4]. Some 
estimates show that autism affects 1 in every 150 children in the United States. This makes it more prevalent than pediatric 
cancer, diabetes and Aids combined. Globally, a number of surveys have been published since 2000, and the majority since 
2006. The diagnostic criteria reflect reliance on modern diagnostic schemes and indicate similar epidemiological findings. As 
ASD is believed to cut across racial, ethnic, socio cultural and geographic boundaries, it is estimated that 67 million children 
maybe affected worldwide. The highest rate of PDD internationally comes from a recent Korean study estimating the prevalence 
to be 189/10 000 [4] followed by a Japanese study estimating the prevalence to be 181.1/10 000 [5].  Robust research from 
the developing and low-income countries focusing on ASD prevalence, etiological risk factors and presentation patterns is still 
lacking. A few reports from the South East Asian and the Eastern Mediterranean region, show a prevalence of 100/ 10 000 in 
Sri Lanka [6], 29/10 000 in the United Arab Emirates [7], 1.4/10 000 in Oman [8], and 6.3/10 000 in Iran [9]. Some smaller 
studies done in India also show a high but variable male-female ratio.Focusing on a broader context than autism, the Move-
ment for Global Mental Health has identified a clear treatment gap, particularly pronounced in low- and middle-income coun-
tries [http://www.globalmentalhealth.org; 10,11]. Epidemiological data on the burden of mental and neurological disorders and 
systematic mapping of relevant services in low- and middle-income countries encouraged World Health Organization (WHO) to 
launch the mental health Gap Action Programme (mhGAP) [12]. Around the same time Autism Speaks, an organization dedicat-
ed to changing the lives of all those who struggle with Autism around the globe, launched the Global Autism Public health 
(GAPH) Initiative. This is an international advocacy effort designed to: (1) enhance public and professional awareness of 
autism, (2) increase clinical and scientific expertise/capacity and promote international research collaboration, (3) enable 
service development and training in early detection and intervention around the world. To this end, Auism Speaks has 
worked collaboratively with a number of countries in the Middle east, Latin America and Asia in areas of training, techni-
cal development and awareness campaign. Epidemiological surveys have been carried out that go beyond providing 
robust prevalence data to resulting in systematic information regarding existing services and may help in assessing the 
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needs and priorities for each community.Characterization of PDD Over time, the definitions of autism have changed as 
illustrated by the numerous diagnostic criteria that were used in both epidemiological and clinical settings. Starting with 
the narrowly defined Kanner's autism, definitions have progressively broadened in the criteria, moving from the Interna-
tional Classification of Diseases (ICD)-9 [WHO, 1975, Diagnostic and Statistical Manual of Mental Disorders (DSM)-III 
[American Psychiatric Association, 1980] and DSM-III-R [American Psychiatric Association, 1987], the ICD-10 [WHO, 
1992] and DSM-IV [American Psychiatric Association, 1994]/DSM-IV-TR [American Psychiatric Association, 2000] and 
most recently the DSM V [American Psychiatric Association, 2013]. The first diagnostic criteria reflected the more quali-
tatively severe forms of the phenotype of autism, usually associated with severe delays in language and cognitive skills. 
Less severe forms of autism started being recognized in the 1980s, and Asperger disorder was not officially recognized 
until the 1990’s. DSM- V, published in 2013, has removed both the diagnosis of Asperger’s and the various subtypes 
of ASDs. Instead ASD appears as a singular diagnosis, with various qualifiers for severity, whereas a diagnosis of Social 
(Pragmatic) communication disorder aims to cover the symptomatology for those with impairments only in communica-
tion. This is important to know as the international nosology offers a standardized methodology in both clinical, training 
and research endeavors.Phenotypic presentation of PDDOverall, very few studies have examined the impact of 
geographical, economic, social and cultural factors directly on the presentation patterns of ASDs; the few that have 
been done indicate little impact. Across some smaller studies done in India, the concern that most commonly led to 
referral from medical professionals was language delay or regression in language skills, followed by social difficulties and 
hyperactivity. Most children received the diagnosis of ASD between 3 and 6 years [13, 14]. The time between recognition 
of symptoms by caregivers and diagnosis averaged about 2 years. It appears that the majority of the families that access 
care in the developing countries come from middle class backgrounds. This maybe because the higher socioeconomic 
families do not attend state-run facilities while the lower socioeconomic groups may not access care unless the child is 
acutely ill. Most often the associated symptoms include seizures, regression of skills and intellectual disabilities; in some 
reports, intellectual disabilities have been found to be present in about 95% of children with ASD.There is a striking 
absence of controlled studies examining the potential impact of environmental and socio-cultural factors on the under-
standing, experience, expression, and help- seeking for autism, especially in the developing countries. There appears to 
be an improvement in the identification of autism in low-resource countries, as inferred from the increase in referrals 
and identified cases. Studies continue to point out that variation in parental education determines their help seeking for 
autism [15] and that it is predominantly severe cases that are currently being identified in poor communities [16,13, 17].Paki-
stan: The Challenge Ahead Advances in autism research are clearly needed to bridge the gap between evidence and 
practice, especially in developing countries where the gap remains large.  To date, robust data on the epidemiological 
burden of ASD in Pakistan remains absent. Literature from developing countries gives a clear indication that the burden 
is considerable; scattered efforts in pediatrics, pediatric neurology and child mental health arena to address the increas-
ing clinical need also point to a burgeoning concern. There is minimal understanding of the disorder at individual, profes-
sional and societal level and therefore an urgent need to enhance awareness and education to decrease stigma that 
maybe associated with autism. Partnering with charities like Autism Speaks is a potential step forward as they partner 
with local stakeholders to develop a culturally appropriate campaign focusing on the need for early diagnosis and inter-
vention. They also provide access to a wide range of educational and informational materials that may be adapted to 
local needs.It continues to be imperative that we invest in research endeavors; one of the main objectives of global 
initiatives is to shed light on the impact of autism on the community. GAPH initiative has developed a number of funding 
mechanisms designed to support the growth of epidemiological research activity and promote international collaborative 
efforts. Similarly, since autism is diagnosed behaviorally, culturally validated and adopted instruments are essential for 
scientific and clinical efforts. Locally translated versions of ADOS and ADI-R would act as gold standard instruments and 
maybe used for research and training purposes.Similarly, joining hands with international partners in service develop-
ment for patients with ASDs is an essential aspect of addressing the increasing burden of the disorder. Services in 
Pakistan are minimal at their best and continue to be of inconsistent quality due to an acute shortage of clinicians with 
sufficient experience in diagnosing and managing autism. There is an urgent need to build capacity for services by 
providing professional development, technical assistance, content development and education. These would focus both 
on clinical-based services as well community-bases interventions, encompassing stakeholders that include parents, 
health professionals as well as early and special education professionals.WHO mhGAP has recently included evidence 
based and simple interventions for ASD and intellectual disabilities that are being tested out in low and middle income 
countries. It is important that as a country with very limited local resources, we utilize a collaborative approach with 
international partners to develop research, training and services for developmental disorders within our current and 
existing health systems.
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